Long-term follow-up of depression in psychiatric care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will re-contact a cohort of 415 patients recruited between 2012 and 2021 who had detailed diagnostic interviews and were genotyped for CYP2D6 and CYP2C19. No new treatments are given; the team will extract clinical data from medical records and national registers for a five-year period after the original participation. Stored blood samples in a biobank allow future biomarker analyses linked to prognosis. The aim is to identify clinical and genetic predictors of long-term course and treatment outcomes in difficult-to-treat depression.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Participation in the study "Pharmacogenetics in depressive patients with specific focus on difficult-to-treat depression, suicide attempt and CYP2D6"

Exclusion Criteria:

Not wanting to participate in the follow-up study

Where it's running

• Research Unit, Office of Psychiatricy, habilitation and technical aid
  Lund, Sweden Recruiting
• Psychiatry Reserach Unit
  Lund, Sweden Active not recruiting

Study contacts

• Study coordinator: Marie Asp, MD, PhD
• Email: marie.asp@skane.se
• Phone: +46702731013

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Two-week smartphone program to boost reward response in people with anhedonia

  This trial tests whether three brief daily smartphone audio exercises teaching positive imagery, savoring, gratitude, and related skills can reduce anhedonia and psychological distress in German-speaking adults with elevated anhedonia and depression.

  Recruiting Philipps University Marburg · Marburg, Hesse · NCT07155941

• SAFETY family-based program for youths after a suicide attempt

  This project will test whether the SAFETY family-based therapy helps 10-17-year-olds who recently attempted suicide avoid repeat attempts.

  Recruiting at 4 sites Karolinska Institutet · Helsingborg and 4 other locations · NCT06931639

• TrueBlue mobile app for tracking depression and anxiety during pregnancy and after birth

  This project will test whether the TrueBlue smartphone app can monitor symptoms of depression, anxiety, and loss of pleasure in people who are pregnant or within 12 weeks after giving birth.

  Recruiting BlueSkeye AI · Nottingham, Nottinghamshire and 1 other locations · NCT06364488

• Exploring L-DOPA for treating depression and anhedonia

  This study is testing if L-DOPA can help people aged 25-55 with depression and lack of pleasure feel better over 8 weeks compared to a placebo.

  Recruiting Phase 4 Emory University · Atlanta, Georgia · NCT06075771

• Using smartphone GPS to study emotions and behaviors

  This study is trying to see how people's feelings and thoughts change in different places by using smartphone GPS and brain scans over four months.

  Recruiting University of Miami · Coral Gables, Florida · NCT05991713

• Investigating the link between inflammation and depression in people with HIV

  This study is testing if an anti-inflammatory drug can help reduce depression symptoms in people with HIV who have high inflammation.

  Recruiting at 2 sites Phase 2 Emory University · Atlanta, Georgia and 1 other locations · NCT05849038

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.